CYAN

Cyanotech Corporation

CYAN, USA

Cyanotech Corporation, an agricultural company, engages in the production and sale of natural ingredients and dietary supplement products from microalgae for health and wellness markets. The company offers BioAstin Hawaiian Astaxanthin, a natural antioxidant to enhance skin, and to support eye, joint, brain, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement to support natural energy, immune system, and cardiovascular health, as well as a source of protein, antioxidant carotenoids, and essential nutrients. It also provides contract extraction, and research and development services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health food, cosmetic manufacturers and nutraceuticals, and dietary supplement markets. It operates in the United States, the Asia-Pacific, Europe, and internationally. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.

https://www.cyanotech.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
CYAN
stock
CYAN

Wall Street Sees Muted Reaction After Noisy Jobs: Markets Wrap Bloomberg.com

Read more →
CYAN
stock
CYAN

Stock exchanges, winds of peace sink defence and oil. Fincantieri thud in Milan (-0.3%), spread at lowest level since 2009 Il Sole 24 ORE

Read more →

Showing 2 of 10

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

0.41

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

0.01 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

0.00 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

0.63 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

1.98

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 0.04% of the total shares of Cyanotech Corporation

1.

SSgA U.S. Extended Market Index Class I

(0.0396%)

since

2023/12/31

2.

NT US Market Cap Idx Fd - L

(0.0049%)

since

2023/12/31

3.

Northern Trust Investments N A

(0%)

since

2024/12/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

No earnings data available.

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Strong Deep Value(8.5)
Defensive
Moderately Defensive(5.5)
Dividend
Weak Dividend Profile(3)
Economic Moat
Some Competitive Advantage(4.8)
GARP
Fair GARP(4)
Growth
Moderate Growth(3.5)
Momentum
No Momentum(2.5)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Moderate Quality(4.5)
Value
Undervalued(7.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.